OMGA - Omega Therapeutics to Participate in Two Upcoming Investor Conferences | Benzinga

CAMBRIDGE, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (NASDAQ:OMGA) ("Omega"), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines, today announced that members of management will participate in fireside chats at two upcoming investor conferences.

Jefferies Cell & Genetic Medicine Summit
Date: Wednesday, September 27, 2023
Time: 8:00 a.m. ET

Chardan's 7^th Annual Genetic Medicines Conference
Date: Tuesday, October 3, 2023
Time: 11:30 a.m. ET

Live webcasts of the presentations will be ...

Full story available on Benzinga.com